期刊文献+

妊娠期高血压疾病患者血清尾加压素Ⅱ水平的变化研究 被引量:1

Levels of Serum Urotensin Ⅱ in Patients with Pregnancy Induced Hypertension
下载PDF
导出
摘要 目的了解妊娠期高血压疾病患者血清尾加压素Ⅱ(UrotensinⅡ,UⅡ)水平及平均动脉压(mean ar-terial pressure,MAP)水平,探讨血清UⅡ在妊娠期高血压疾病发病中的作用。方法选择96例妊娠期高血压疾病患者,其中妊娠期高血压组30例、子痫前期轻度组28例、子痫前期重度组38例;40例正常晚孕妇女为正常妊娠组,采用放射免疫法检测4组孕妇外周血中血清UⅡ水平,同时测定MAP。结果(1)子痫前期轻、重度组与正常妊娠组孕妇血清UⅡ水平间差异有显著性意义(P<0.05),子痫前期轻度组与重度组血清UⅡ水平间差异有显著性意义(P<0.05),妊娠期高血压组与正常妊娠组血清UⅡ水平间差异无显著性意义(P>0.05)。(2)妊娠期高血压疾病各组与正常妊娠组MAP水平间差异有显著性意义(P<0.01)。(3)4组患者血清UⅡ水平与MAP均呈正相关(P<0.001)。结论妊娠期高血压疾病子痫前期患者血清UⅡ水平明显高于正常妊娠妇女,UⅡ可能参与了妊娠期高血压疾病的发生、发展过程。 Objective To detect the levels of serum urotensin Ⅱ(UⅡ) in patients with pregnancy induced hypertension(PIH) and measure mean arterial pressure(MAP) so as to investigate the role of UⅡin PIH.Methods The levels of serum UⅡof peripheral blood were detected from 96 patients with PIH(PIH group,n=30),with mild preeclampsia(mPE group,n=28),and with severe preeclampsia(sPE group,n=38),and 40 normal pregnancy women(control group) by radioimmunoassay,and the MAPs were also taken.Among the four group,there was no significant difference in age and gestational age(P〉0.05).Results(1) In level of serum UⅡ there were significant differences among the mPE,sPE and control groups(P〈0.05);there was significant differences between mPE and sPE groups(P〈0.05);,there was no significant difference between PIH and control groups(P〉0.05);(2) In the level of MAP,there were significant differences between each disease group and control group(P〈0.01).(3)The level of UⅡwas positively correlated with that of MAP in all four groups(P〈0.001).Conclusion The level of serum UⅡin patients with preeclampsia is obviously higher than that in normal pregnancy women,UⅡmay be involved in the onset and development of PIH.
出处 《中国全科医学》 CAS CSCD 2007年第21期1774-1775,共2页 Chinese General Practice
关键词 高血压 妊娠性 尾加压素Ⅱ 放射免疫测定 平均动脉压 Hypertension,pregnancy Urotensin Ⅱ Radioimmunoassay Measure mean arterial pressure
  • 相关文献

参考文献7

  • 1Watanahe T,Suguro T,kanome T,et al.Human urotensinⅡ accelerates foa-m cell formation in human monocyte derived macrophages[J].Hypertension,2005,469:738-744.
  • 2Totsune K,Takahashi K,Arihara Z,et al.Increased plasma urotensin Ⅱ lev-els in patients with diabetes mellitus[J].Clin Sci,2003,104(1):1-5.
  • 3Rossowski WJ,Cheng BL,Taylor JE,et al.Human urotensin Ⅱ induced aortaring contractions are mediated by protein kinase G,tyrosine kinase andRbo kinase:inbihition by somatostatin receptor agonists[J].Eur J Pharmacol,2002,438:159-170.
  • 4Ames RS,Sarau HM,Chambers JK,et al.Human urotensin Ⅱis a potent vasoconstrictor and agonist for the orphan receptor GRP14[J].Nature,1999,401:282-286.
  • 5Krum H,Kemp W.Therapeutic potential of blockade of the urotensin Ⅱ sy-stem in systemic hypertension[J].Curr Hypertens Rep,2007,9(1):53-58.
  • 6顾晓龙,严全能,张园,李志梁,刘映峰,张宏兵,冼江.尾加压素Ⅱ对人脐静脉内皮细胞凋亡的影响[J].实用医学杂志,2006,22(11):1228-1230. 被引量:3
  • 7吴曼祯,陈文,陈秀华,黄远征,卢冬青.血β-绒毛膜促性腺激素、血钙、血细胞比容、平均动脉压在预测妊娠高血压综合征中的价值[J].中国全科医学,2006,9(4):295-296. 被引量:19

二级参考文献15

  • 1陈世雄,刘正湘.动脉粥样硬化病灶中的细胞凋亡与增殖[J].实用心脑肺血管病杂志,2004,12(5):298-301. 被引量:1
  • 2Chare Dong Hsu.Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia[J].AM J Obstet Gynecol,1994,170(2):1135.
  • 3Said MS.Beta-human chorionic gonadotropin levels before and after the development of preeclampsia[J].Br J Obstet Gynaecol,1984,91(2):772.
  • 4刘映舜.高危妊娠监护治疗学[M].北京:北京医科大学、中国协和医科大学联合出版社,1997.61.
  • 5BOMBELI T,KARSAN A,TAIT J F,et al.Apoptotic vascular endothelial cells become procoagulant[J].Blood,1997,89(7):2429-2442.
  • 6BOMBELI T,SCHWARTZ B R,HARLAN J M.Endothelial cells undergoing apoptosis become pro adhesive for non activated platelets[J].Blood,1999,93(8):3831-3838.
  • 7MALLAT Z,HUGEL B,OHAN J,et al.Shed membrane micro particles with procoagulant potential in human atherosclerotic plaques:a role for apoptosis in plaque thrombogenicity[J].Circulation,1999,99(4):348-353.
  • 8DIMMELER S,ZEIHER A M.Endothelial cell apoptosis in angiogenesis and vessel regression[J].Girc Res,2000,87 (1):434 -439.
  • 9CONLON J M,YANO K,WAUGH D,et al.Distribution and molecular forms of urotensin Ⅱ and its function in cardiovascular regulation in vertebrates[J].J Exp Zool,1996,275(3):226-238.
  • 10D'eMEYER G R Y,HERMAN A G.Vascular endothelial dysfunction[J].Cardiovasc Dis,1997,39(6):325-328.

共引文献20

同被引文献7

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部